Women who receive false-positive results from routine breast cancer screenings may experience a low quality of life and feelings of anxiety for at least one year, according to a study published online Dec. 20 in the British Journal of Surgery.
TUESDAY, Jan. 25 (HealthDay News) -- Women who receive false-positive results from routine breast cancer screenings may experience a low quality of life and feelings of anxiety for at least one year, according to a study published online Dec. 20 in the British Journal of Surgery.
Alida F.W. van der Steeg, M.D., from the St. Elisabeth Hospital in Lilburg, Netherlands, and colleagues conducted a longitudinal study, measuring the quality of life of 385 women diagnosed with breast disease, between September 2002 and January 2007. Of these women, 152 were correctly diagnosed with breast cancer and 233 women had false-positive mammogram results. Anxiety and quality of life were assessed in these women before diagnosis and during the 12 months following.
The researchers found that significantly more histological biopsies were required in the false-positive group. Almost 60 percent of the false-positive group revisited the outpatient clinic during the first year. Women in the false-positive group with the highest scores on trait anxiety scored lowest on the quality-of-life assessment, and they reported more feelings of anxiety, compared to women with lower trait anxiety scores in either the false-positive or breast cancer groups.
"Women deserve more balanced information to help them choose whether or not to accept an invitation for screening mammography. This should not only focus on the supposed benefits, but should include potential side effects, such as increased feelings of anxiety," the authors write.
Phase 2b safety data for Sildenafil Cream against FSAD reported
August 26th 2024In a recent study published in The Journal of Sexual Medicine, Sildenafil Cream, 3.6% was indicated as safe and well-tolerated for use against female sexual arousal disorder in healthy premenopausal women.
Read More
Study: Pelvic floor dilator reduces pelvic floor muscle injury during vaginal delivery
August 6th 2024A new pilot study published in the International Urogynecology Journal found that Materna Medical’s Prep Device, a pelvic floor dilator, reduced full levator ani muscle avulsion during vaginal delivery in first-time mothers.
Read More